Delphia Therapeutics
Cambridge, United States · Founded 2024 · $67.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2B
- Website
- delphiatx.com
- Total Funding
- $67.0M
- Last Round
- $67.0M Series AMay 2024
- Rounds
- 1
About
Biotech developing 'activation lethality' cancer therapeutics that overactivate oncogenes to selectively kill tumor cells.
Summary
Delphia Therapeutics is a Biotech company based in Cambridge, United States, founded in 2024. It has raised $67.0M in total across 1 round, most recently a $67.0M Series A round in May 2024. Investors include Nextech Invest, Alexandria Venture Investments and Polaris Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2024
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/delphia-therapeutics"><img src="https://indexed.vc/api/badge/company/delphia-therapeutics" alt="Delphia Therapeutics on Indexed.vc" width="260" height="76" /></a>